CRSP
CRISPR Therapeutics AG (CRSP) Investor Questions
Review CRISPR Therapeutics AG (CRSP) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- CRISPR Therapeutics AG
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 43
- Annual revenue
- $3.51M
- Annual net income
- $-581.60M
- Annual free cash flow
- $-345.93M
CRISPR Therapeutics AG (CRSP) Investor Questions research
CRISPR Therapeutics AG trades under the ticker CRSP. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review CRSP through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.